Zenith® Dissection Clinical Trial

NACompletedINTERVENTIONAL
Enrollment

73

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

February 28, 2015

Study Completion Date

January 27, 2020

Conditions
Aortic Dissection
Interventions
DEVICE

Endovascular Treatment (Zenith)

Instead of making a large incision in the chest, the physician makes a small incision near each hip to insert, and guides the study device(s) into place in the aorta.

Trial Locations (24)

10016

New York University Hospital, New York

15212

Allegheny General Hospital, Pittsburgh

15213

University of Pittsburgh Medical Center, Pittsburgh

19104

Hospital of the University of Pennsylvania, Philadelphia

22908

University of Virginia Medical Center, Charlottesville

23507

Sentara Vascular Specialists, Norfolk

27710

Duke University Medical Center, Durham

32610

University of Florida, Gainesville

33606

University of South Florida, Tampa

45219

The Christ Hospital, Cincinnati

46250

Indiana Heart Hospital, Indianapolis

48109

University of Michigan Hospital, Ann Arbor

63110

Barnes-Jewish Hospital, St Louis

76508

Scott and White Hospital, Temple

77030

The Methodist Hospital, Houston

90048

Cedars-Sinai Medical Center, Los Angeles

98104

University of Washington-Harborview Medical Center, Seattle

02114

Massachusetts General Hospital, Boston

02215

Beth Israel Deaconess Medical Center, Boston

01655

University of Massachusetts, Worcester

03756

Dartmouth Hitchcock Medical Center, Lebanon

08103

Cooper University Hospital, Camden

07601

Hackensack University Medical Center, Hackensack

Unknown

Jikei University School of Medicine, Tokyo

All Listed Sponsors
lead

Cook Research Incorporated

INDUSTRY

NCT01568320 - Zenith® Dissection Clinical Trial | Biotech Hunter | Biotech Hunter